{
    "nctId": "NCT06396754",
    "briefTitle": "Deployment and Clinical Evaluation of an AI-powered Digital Oncology Biomarker Tool to guidE Treatment in TNBC",
    "officialTitle": "Deployment and Clinical Evaluation of an AI-powered Digital Oncology Biomarker Tool to guidE Treatment in TNBC",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Triple Negative Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "To determine the reliability and performance of the process and AI tool",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u226518 years\n* Confirmed diagnosis of triple negative breast cancer (non-metastatic)\n* Planned for neo-adjuvant systemic therapy\n* Written consent to generic Tissue for Research donation\n\nExclusion Criteria:\n\n* Patients declined consent for generic Tissue for Research donation",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}